Valerio Therapeutics Société anonyme (EPA: ALVIO)
France
· Delayed Price · Currency is EUR 0.0780
+0.0010 (1.30%)
Jan 30, 2025, 3:13 PM CET
EPA: ALVIO Revenue
Valerio Therapeutics Société anonyme had revenue of 89.00K EUR in the half year ending June 30, 2024. This brings the company's revenue in the last twelve months to 1.89M, up 30.91% year-over-year. In the year 2023, Valerio Therapeutics Société anonyme had annual revenue of 1.80M with 24.74% growth.
Revenue (ttm)
1.89M
Revenue Growth
+30.91%
P/S Ratio
6.57
Revenue / Employee
49.71K
Employees
19
Market Cap
12.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.80M | 357.00K | 24.74% |
| Dec 31, 2022 | 1.44M | -2.62M | -64.48% |
| Dec 31, 2021 | 4.06M | 2.29M | 128.72% |
| Dec 31, 2020 | 1.78M | -2.51M | -58.59% |
| Dec 31, 2019 | 4.29M | -1.84M | -30.00% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech | 2.74B |
| bioMérieux | 3.81B |
| Ipsen | 3.44B |
| Eurofins Scientific SE | 6.72B |
| Virbac | 1.34B |
| Ramsay Générale de Santé | 5.01B |